Close Menu
Search
Reinventing Medicine
Redefining Treatment Paradigms
About Us
Our Company
Leadership
Kymera Cares
Science & Innovation
Our Approach
Pipeline
Resource Library
Careers & Culture
Working at Kymera
Open Positions
Patients
Media
Investors
Patients
Media
Investors
Reinventing Medicine
Redefining Treatment Paradigms
About Us
Our Company
Leadership
Kymera Cares
Science & Innovation
Our Approach
Pipeline
Resource Library
Careers & Culture
Working at Kymera
Open Positions
Search
Back to All Resources
Drugging Tissue-Restricted E3 Ligases
May 26, 2021
Ligase Targeting Drug Development Summit
View Presentation
Area of Focus
Platform
Targeted Protein Degradation
Programs
Other
Development Stage
Pre-clinical Data
Share
You may also be interested in these resources
August 15, 2022
MQAtlas Creates a Deep, Accurate and Global E3 Expression Atlas Enabling Targeted Protein Degradation Based Precision Medicine
The 14th International Symposium on Mass Spectrometry in the Health and Life Sciences
View Resource
December 7, 2022
Proteomics enabling TPD Drug Discovery
TPD Assay Development and Screening Summit
View Resource